These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 25440154)

  • 1. In vivo activity of daptomycin/colistin combination therapy in a Galleria mellonella model of Acinetobacter baumannii infection.
    Yang H; Chen G; Hu L; Liu Y; Cheng J; Li H; Ye Y; Li J
    Int J Antimicrob Agents; 2015 Feb; 45(2):188-91. PubMed ID: 25440154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo efficacy of telavancin/colistin combination therapy in a Galleria mellonella model of Acinetobacter baumannii infection.
    Hornsey M; Phee L; Longshaw C; Wareham DW
    Int J Antimicrob Agents; 2013 Mar; 41(3):285-7. PubMed ID: 23312607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo activity of vancomycin combined with colistin against multidrug-resistant strains of Acinetobacter baumannii in a Galleria mellonella model.
    Yang H; Lv N; Hu L; Liu Y; Cheng J; Ye Y; Li J
    Infect Dis (Lond); 2016; 48(3):189-94. PubMed ID: 26503239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of levofloxacin in combination with colistin against Acinetobacter baumannii: In vitro and in a Galleria mellonella model.
    Wei W; Yang H; Hu L; Ye Y; Li J
    J Microbiol Immunol Infect; 2017 Dec; 50(6):821-830. PubMed ID: 26725481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colistin/daptomycin: an unconventional antimicrobial combination synergistic in vitro against multidrug-resistant Acinetobacter baumannii.
    Galani I; Orlandou K; Moraitou H; Petrikkos G; Souli M
    Int J Antimicrob Agents; 2014 Apr; 43(4):370-4. PubMed ID: 24560919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo activity of co-trimoxazole combined with colistin against Acinetobacter baumannii producing OXA-23 in a Galleria mellonella model.
    Khalil MAF; Moawad SS; Hefzy EM
    J Med Microbiol; 2019 Jan; 68(1):52-59. PubMed ID: 30422109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colistin enhances therapeutic efficacy of daptomycin or teicoplanin in a murine model of multiresistant Acinetobacter baumannii sepsis.
    Cirioni O; Simonetti O; Pierpaoli E; Barucca A; Ghiselli R; Orlando F; Pelloni M; Trombettoni MM; Guerrieri M; Offidani A; Giacometti A; Provinciali M
    Diagn Microbiol Infect Dis; 2016 Dec; 86(4):392-398. PubMed ID: 27712928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
    Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
    Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro effects of tigecycline in combination with colistin (polymyxin E) and sulbactam against multidrug-resistant Acinetobacter baumannii.
    Ni W; Cui J; Liang B; Cai Y; Bai N; Cai X; Wang R
    J Antibiot (Tokyo); 2013 Dec; 66(12):705-8. PubMed ID: 23981963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo efficacy of glycopeptide-colistin combination therapies in a Galleria mellonella model of Acinetobacter baumannii infection.
    Hornsey M; Wareham DW
    Antimicrob Agents Chemother; 2011 Jul; 55(7):3534-7. PubMed ID: 21502628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of doripenem in combination with various antimicrobials against multidrug-resistant Acinetobacter baumannii: possible options for the treatment of complicated infection.
    Principe L; Capone A; Mazzarelli A; D'Arezzo S; Bordi E; Di Caro A; Petrosillo N
    Microb Drug Resist; 2013 Oct; 19(5):407-14. PubMed ID: 23659601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergy against extensively drug-resistant Acinetobacter baumannii in vitro by two old antibiotics: colistin and chloramphenicol.
    Wei WJ; Yang HF
    Int J Antimicrob Agents; 2017 Mar; 49(3):321-326. PubMed ID: 28167347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced efficacy of imipenem-colistin combination therapy against multiple-drug-resistant Enterobacter cloacae: in vitro activity and a Galleria mellonella model.
    Yang H; Chen G; Hu L; Liu Y; Cheng J; Ye Y; Li J
    J Microbiol Immunol Infect; 2018 Feb; 51(1):70-75. PubMed ID: 26906264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of tigecycline/colistin combination in a pneumonia model caused by extensively drug-resistant Acinetobacter baumannii.
    Mutlu Yilmaz E; Sunbul M; Aksoy A; Yilmaz H; Guney AK; Guvenc T
    Int J Antimicrob Agents; 2012 Oct; 40(4):332-6. PubMed ID: 22831842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of teicoplanin combined with colistin versus multidrug-resistant strains of Acinetobacter baumannii.
    Wareham DW; Gordon NC; Hornsey M
    J Antimicrob Chemother; 2011 May; 66(5):1047-51. PubMed ID: 21393131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Vitro Activities of Novel Antimicrobial Combinations against Extensively Drug-Resistant Acinetobacter baumannii.
    Córdoba J; Coronado-Álvarez NM; Parra D; Parra-Ruiz J
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7316-9. PubMed ID: 26369956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Daptomycin as adjunctive treatment for experimental infection by Acinetobacter baumannii with resistance to colistin.
    Poulakou G; Renieris G; Sabrakos L; Zarkotou O; Themeli-Digalaki K; Perivolioti E; Kraniotaki E; Giamarellos-Bourboulis EJ; Zavras N
    Int J Antimicrob Agents; 2019 Feb; 53(2):190-194. PubMed ID: 30391645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of vancomycin in addition with colistin and meropenem against colistin-sensitive multidrug resistant Acinetobacter baumannii causing severe infections in a Paediatric Intensive Care Unit.
    Ceccarelli G; Oliva A; d'Ettorre G; D'Abramo A; Caresta E; Barbara CS; Mascellino MT; Papoff P; Moretti C; Vullo V; Visca P; Venditti M
    BMC Infect Dis; 2015 Sep; 15():393. PubMed ID: 26424078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activities of rifampin, colistin, sulbactam and tigecycline tested alone and in combination against extensively drug-resistant Acinetobacter baumannii.
    Dong X; Chen F; Zhang Y; Liu H; Liu Y; Ma L
    J Antibiot (Tokyo); 2014 Sep; 67(9):677-80. PubMed ID: 25095805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial effects of varied combinations of meropenem, sulbactam, and colistin on a multidrug-resistant Acinetobacter baumannii isolate that caused meningitis and bacteremia.
    Lee CH; Tang YF; Su LH; Chien CC; Liu JW
    Microb Drug Resist; 2008 Sep; 14(3):233-7. PubMed ID: 18707240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.